In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company ... Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from the index.
Illumina, Inc. (NASDAQ ... due to its controversial multi-billion dollar deal to acquire cancer test maker Grail Inc (NASDAQ:GRAL). Also NORTHAMPTON, MA / ACCESSWIRE / December 16, 2024 ...
Volunteers aged between 50 and 77 are being sought to trial the diagnostic developed by California biotech Grail, which spun out of Illumina in 2016 and agreed to be reacquired by the lab ...